Ravi Salgia to Immunotherapy
This is a "connection" page, showing publications Ravi Salgia has written about Immunotherapy.
Connection Strength
1.988
-
Cancer Immunotherapy-An Overview. Cancer Treat Res. 2025; 129:1-16.
Score: 0.578
-
Phenotypic Plasticity, Non-genetic Mechanisms, and Immune Drug Resistance in Cancer. Cancer Treat Res. 2025; 129:309-324.
Score: 0.578
-
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations. J Immunother Cancer. 2018 01 23; 6(1):8.
Score: 0.357
-
Immunotherapy in Head and Neck Cancer. Cancer Treat Res. 2025; 129:119-156.
Score: 0.144
-
Complete response to chemoimmunotherapy with bevacizumab in synchronous multiple primary cancers: pulmonary adenocarcinoma and sarcomatoid carcinoma. Cold Spring Harb Mol Case Stud. 2023 04; 9(2).
Score: 0.129
-
Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024. Cancer. 2025 Sep 01; 131(17):e70060.
Score: 0.038
-
Proceedings of the 1st biannual bridging the gaps in lung cancer conference. Oncologist. 2025 Feb 06; 30(2).
Score: 0.036
-
Gynecological cancer tumor Microenvironment: Unveiling cellular complexity and therapeutic potential. Biochem Pharmacol. 2024 11; 229:116498.
Score: 0.035
-
Exploring markers of immunoresponsiveness in papillary thyroid carcinoma and future treatment strategies. J Immunother Cancer. 2024 Jul 29; 12(7).
Score: 0.035
-
Epigenetic landscape of small cell lung cancer: small image of a giant recalcitrant disease. Semin Cancer Biol. 2022 08; 83:57-76.
Score: 0.027
-
Molecularly targeted therapies in non-small-cell lung cancer annual update 2014. J Thorac Oncol. 2015 Jan; 10(1 Suppl 1):S1-63.
Score: 0.018
-
Concerted potent humoral immune responses to autoantigens are associated with tumor destruction and favorable clinical outcomes without autoimmunity. Clin Cancer Res. 2008 Jun 15; 14(12):3896-905.
Score: 0.011